Title:
ANTI-CD39 NANOBODY AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/186121
Kind Code:
A1
Abstract:
The present invention relates to a nanobody or antigen-binding fragment thereof capable of specifically binding to CD39, a multi-specific antibody comprising the nanobody or antigen-binding fragment thereof, a nucleic acid encoding the nanobody or antigen-binding fragment thereof and a host cell comprising the nucleic acid, as well as relevant use thereof. The invention further relates to the prophylactic, therapeutic, diagnostic and/or detecting use of the nanobody or antigen-binding fragment thereof or the multi-specific antibody.
Inventors:
ZHANG ZHENQING (CN)
JIA YUNLI (CN)
XU YIFENG (CN)
MIAO XIAONIU (CN)
LI ZHIYUAN (CN)
TSUN ANDY (CN)
JIA YUNLI (CN)
XU YIFENG (CN)
MIAO XIAONIU (CN)
LI ZHIYUAN (CN)
TSUN ANDY (CN)
Application Number:
PCT/CN2023/085567
Publication Date:
October 05, 2023
Filing Date:
March 31, 2023
Export Citation:
Assignee:
BIOTHEUS INC (CN)
International Classes:
C07K16/28; A61K39/395; A61K47/64; A61K48/00; A61P31/00; A61P35/00; C07K16/40; C12N1/21; C12N5/10; C12N15/13; C12N15/63; C12P21/08; G01N33/53
Domestic Patent References:
| WO2021259199A1 | 2021-12-30 |
Foreign References:
| CA3149494A1 | 2021-02-18 | |||
| CN110407941A | 2019-11-05 | |||
| CN114773473A | 2022-07-22 | |||
| AU2020447878A1 | 2023-02-02 | |||
| CN108299561A | 2018-07-20 | |||
| US20220389111A1 | 2022-12-08 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: ANTI-SERUM ALBUMIN NANOBODY AND DERIVATIVE THEREOF
Next Patent: COUNTERCURRENT FLOW MIXING DEVICE AND METHOD FOR LIPOSOME SYNTHESIS
Next Patent: COUNTERCURRENT FLOW MIXING DEVICE AND METHOD FOR LIPOSOME SYNTHESIS